| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.841 | 0.004 | 0.841 | Aldehyde oxidase inhibitor | 0.156 0.133 CID_154699900 | ||
| 0.763 | 0.016 | 0.763 | Caspase 9 stimulant | 0.725 0.021 CID_154699900 | ||
| 0.721 | 0.004 | 0.809 | Histamine release inhibitor | 0.809 0.003 CID_154699900 | CID_154699900 | |
| 0.707 | 0.004 | 0.753 | 5 Hydroxytryptamine release inhibitor | 0.753 0.004 CID_154699900 | CID_154699900 | |
| 0.725 | 0.027 | 0.776 | Apoptosis agonist | 0.776 0.019 CID_154699900 | CID_154699900 | |
| 0.659 | 0.003 | 0.659 | Cystathionine beta-synthase inhibitor | 0.536 0.003 CID_154699900 | ||
| 0.64 | 0.008 | 0.64 | Caspase 3 stimulant | 0.541 0.015 CID_154699900 | ||
| 0.637 | 0.01 | 0.637 | 12-Lipoxygenase inhibitor | |||
| 0.622 | 0.004 | 0.622 | Peroxidase inhibitor | |||
| 0.614 | 0.01 | 0.772 | Antioxidant | 0.772 0.005 CID_154699900 | CID_154699900 | |
| 0.607 | 0.008 | 0.723 | Free radical scavenger | 0.723 0.005 CID_154699900 | CID_154699900 | |
| 0.599 | 0.008 | 0.599 | GABA C receptor rho-3 antagonist | |||
| 0.61 | 0.022 | 0.61 | 15-Lipoxygenase inhibitor | |||
| 0.584 | 0.004 | 0.584 | Estrogen antagonist | 0.168 0.018 CID_154699900 | ||
| 0.574 | 0.004 | 0.574 | Aldehyde dehydrogenase inhibitor | 0.459 0.005 CID_154699900 | ||
| 0.557 | 0.019 | 0.557 | Aryl hydrocarbon receptor agonist | 0.179 0.115 CID_154699900 | ||
| 0.523 | 0.004 | 0.523 | Estrogen receptor beta antagonist | 0.108 0.05 CID_154699900 | ||
| 0.533 | 0.015 | 0.533 | Lipoxygenase inhibitor | |||
| 0.53 | 0.04 | 0.789 | Transcription factor NF kappa B inhibitor | 0.789 0.014 CID_154699900 | CID_154699900 | |
| 0.498 | 0.014 | 0.52 | DNA damaging | 0.52 0.012 CID_154699900 | CID_154699900 | |
| 0.494 | 0.014 | 0.494 | Amyloid beta aggregation inhibitor | 0.319 0.042 CID_154699900 | ||
| 0.513 | 0.039 | 0.513 | Prostaglandin dehydrogenase inhibitor | |||
| 0.478 | 0.005 | 0.478 | 5 Hydroxytryptamine uptake stimulant | 0.211 0.131 CID_154699900 | ||
| 0.475 | 0.007 | 0.491 | Topoisomerase II inhibitor | 0.491 0.007 CID_154699900 | CID_154699900 | |
| 0.471 | 0.005 | 0.471 | Cyclooxygenase 1 inhibitor | 0.277 0.017 CID_154699900 | ||
| 0.468 | 0.005 | 0.468 | Cyclooxygenase inhibitor | 0.322 0.014 CID_154699900 | ||
| 0.534 | 0.071 | 0.76 | Alpha-glucosidase inhibitor | 0.76 0.024 CID_154699900 | CID_154699900 | |
| 0.427 | 0.003 | 0.427 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.102 0.036 CID_154699900 | ||
| 0.495 | 0.09 | 0.817 | Antiinflammatory | 0.817 0.013 CID_154699900 | CID_154699900 | |
| 0.408 | 0.005 | 0.414 | Neurotrophic factor enhancer | 0.414 0.005 CID_154699900 | CID_154699900 | |
| 0.399 | 0.003 | 0.399 | CDC25A inhibitor | 0.206 0.006 CID_154699900 | ||
| 0.396 | 0.005 | 0.396 | Cyclooxygenase 2 inhibitor | 0.278 0.016 CID_154699900 | ||
| 0.387 | 0.004 | 0.387 | Estrogen receptor alpha antagonist | |||
| 0.383 | 0.005 | 0.531 | Xanthine oxidase inhibitor | 0.531 0.004 CID_154699900 | CID_154699900 | |
| 0.387 | 0.01 | 0.387 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.381 | 0.008 | 0.381 | DNA intercalator | 0.35 0.009 CID_154699900 | ||
| 0.374 | 0.004 | 0.374 | Estrogen agonist | 0.166 0.01 CID_154699900 | ||
| 0.367 | 0.005 | 0.367 | Topoisomerase II alpha inhibitor | 0.357 0.005 CID_154699900 | ||
| 0.366 | 0.01 | 0.366 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.288 0.027 CID_154699900 | ||
| 0.388 | 0.033 | 0.416 | Hypoxia-inducible factor 1 alpha inhibitor | 0.416 0.026 CID_154699900 | CID_154699900 | |
| 0.365 | 0.014 | 0.365 | MAO inhibitor | |||
| 0.349 | 0.004 | 0.349 | Macrophage migration inhibitory factor inhibitor | |||
| 0.355 | 0.011 | 0.355 | MAO A inhibitor | |||
| 0.347 | 0.004 | 0.347 | CD45 antagonist | |||
| 0.344 | 0.005 | 0.344 | Carbonic anhydrase XIII inhibitor | 0.325 0.005 CID_154699900 | ||
| 0.352 | 0.016 | 0.528 | Melanin inhibitor | 0.528 0.006 CID_154699900 | CID_154699900 | |
| 0.409 | 0.073 | 0.683 | Antibacterial | 0.683 0.01 CID_154699900 | CID_154699900 | |
| 0.337 | 0.004 | 0.468 | Photosensitizer | 0.468 0.003 CID_154699900 | CID_154699900 | |
| 0.408 | 0.076 | 0.408 | Calcium channel L-type activator | |||
| 0.333 | 0.005 | 0.333 | Carbonic anhydrase VI inhibitor | 0.144 0.022 CID_154699900 | ||
| 0.361 | 0.033 | 0.361 | Sodium/bile acid cotransporter inhibitor | 0.276 0.101 CID_154699900 | ||
| 0.358 | 0.031 | 0.55 | Nitric oxide antagonist | 0.55 0.012 CID_154699900 | CID_154699900 | |
| 0.36 | 0.034 | 0.36 | Superoxide dismutase inhibitor | |||
| 0.345 | 0.02 | 0.588 | Non-steroidal antiinflammatory agent | 0.588 0.004 CID_154699900 | CID_154699900 | |
| 0.329 | 0.006 | 0.329 | Carbonic anhydrase XV inhibitor | |||
| 0.355 | 0.032 | 0.355 | Transcription factor STAT inhibitor | |||
| 0.337 | 0.014 | 0.656 | Amylase inhibitor | 0.656 0.003 CID_154699900 | CID_154699900 | |
| 0.349 | 0.033 | 0.452 | Vasodilator | 0.452 0.016 CID_154699900 | CID_154699900 | |
| 0.329 | 0.014 | 0.329 | Bone formation stimulant | 0.211 0.033 CID_154699900 | ||
| 0.324 | 0.009 | 0.373 | Topoisomerase I inhibitor | 0.373 0.006 CID_154699900 | CID_154699900 | |
| 0.32 | 0.015 | 0.42 | NOS3 expression enhancer | 0.42 0.007 CID_154699900 | CID_154699900 | |
| 0.308 | 0.006 | 0.308 | Histidine decarboxylase inhibitor | |||
| 0.338 | 0.037 | 0.338 | Transcription factor STAT3 inhibitor | 0.185 0.157 CID_154699900 | ||
| 0.307 | 0.01 | 0.307 | Succinate dehydrogenase inhibitor | 0.157 0.1 CID_154699900 | ||
| 0.299 | 0.004 | 0.299 | Estrogen receptor beta agonist | 0.12 0.009 CID_154699900 | ||
| 0.301 | 0.009 | 0.301 | Interleukin 4 antagonist | 0.215 0.019 CID_154699900 | ||
| 0.304 | 0.013 | 0.304 | Acetylcholinesterase inhibitor | |||
| 0.332 | 0.041 | 0.332 | Insulysin inhibitor | |||
| 0.301 | 0.01 | 0.301 | 5-Lipoxygenase inhibitor | |||
| 0.29 | 0.006 | 0.29 | Carbonic anhydrase III inhibitor | 0.161 0.025 CID_154699900 | ||
| 0.29 | 0.007 | 0.465 | ATPase inhibitor | 0.465 0.003 CID_154699900 | CID_154699900 | |
| 0.309 | 0.027 | 0.309 | Dual specificity phosphatase 3 inhibitor | |||
| 0.298 | 0.019 | 0.298 | Protein-tyrosine phosphatase inhibitor | 0.241 0.033 CID_154699900 | ||
| 0.291 | 0.013 | 0.291 | MAO B inhibitor | |||
| 0.279 | 0.004 | 0.279 | Creatine kinase inhibitor | |||
| 0.31 | 0.038 | 0.462 | Cyclic AMP phosphodiesterase inhibitor | 0.462 0.009 CID_154699900 | CID_154699900 | |
| 0.275 | 0.004 | 0.275 | Papain-like protease (SARS coronavirus) inhibitor | 0.144 0.04 CID_154699900 | ||
| 0.275 | 0.008 | 0.275 | GABA C receptor rho-2 antagonist | |||
| 0.286 | 0.019 | 0.546 | Monophenol monooxygenase inhibitor | 0.546 0.006 CID_154699900 | CID_154699900 | |
| 0.352 | 0.086 | 0.545 | Immunosuppressant | 0.545 0.022 CID_154699900 | CID_154699900 | |
| 0.33 | 0.066 | 0.533 | Apoptosis antagonist | 0.533 0.016 CID_154699900 | CID_154699900 | |
| 0.292 | 0.032 | 0.566 | Hepatoprotectant | 0.566 0.005 CID_154699900 | CID_154699900 | |
| 0.302 | 0.051 | 0.402 | Antiamyloidogenic | 0.402 0.028 CID_154699900 | CID_154699900 | |
| 0.314 | 0.065 | 0.401 | Spasmolytic | 0.401 0.04 CID_154699900 | CID_154699900 | |
| 0.282 | 0.036 | 0.282 | RNA-directed DNA polymerase inhibitor | 0.235 0.06 CID_154699900 | ||
| 0.271 | 0.029 | 0.271 | Mcl-1 antagonist | |||
| 0.247 | 0.008 | 0.247 | Alcohol dehydrogenase inhibitor | 0.171 0.016 CID_154699900 | ||
| 0.258 | 0.027 | 0.413 | Interferon gamma antagonist | 0.413 0.01 CID_154699900 | CID_154699900 | |
| 0.265 | 0.035 | 0.265 | Dual specificity phosphatase inhibitor | |||
| 0.243 | 0.014 | 0.256 | Mannose-6-phosphate isomerase inhibitor | 0.256 0.011 CID_154699900 | CID_154699900 | |
| 0.249 | 0.02 | 0.249 | Alkaline phosphatase inhibitor | 0.249 0.02 CID_154699900 | ||
| 0.237 | 0.011 | 0.237 | Toll-Like receptor 2 antagonist | |||
| 0.309 | 0.083 | 0.309 | Calcium channel activator | |||
| 0.25 | 0.026 | 0.41 | Protein kinase stimulant | 0.41 0.008 CID_154699900 | CID_154699900 | |
| 0.306 | 0.083 | 0.474 | Vasodilator, coronary | 0.474 0.019 CID_154699900 | CID_154699900 | |
| 0.25 | 0.027 | 0.363 | Lipid peroxidase inhibitor | 0.363 0.012 CID_154699900 | CID_154699900 | |
| 0.358 | 0.136 | 0.358 | DNA polymerase beta inhibitor | |||
| 0.249 | 0.033 | 0.249 | Nitric-oxide synthase stimulant | 0.248 0.033 CID_154699900 | ||
| 0.224 | 0.009 | 0.224 | Protein kinase C mu inhibitor | |||
| 0.243 | 0.03 | 0.243 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.292 | 0.081 | 0.555 | Immunostimulant | 0.555 0.022 CID_154699900 | CID_154699900 | |
| 0.261 | 0.058 | 0.261 | Pyruvate kinase inhibitor | |||
| 0.208 | 0.005 | 0.212 | Heat shock protein 70 antagonist | 0.212 0.005 CID_154699900 | CID_154699900 | |
| 0.228 | 0.027 | 0.228 | Heat shock protein 90 antagonist | |||
| 0.276 | 0.078 | 0.276 | 5 Hydroxytryptamine release stimulant | 0.184 0.136 CID_154699900 | ||
| 0.263 | 0.069 | 0.688 | Hypoglycemic | 0.688 0.005 CID_154699900 | CID_154699900 | |
| 0.337 | 0.144 | 0.337 | DNA directed DNA polymerase inhibitor | |||
| 0.223 | 0.03 | 0.304 | Interleukin 6 antagonist | 0.304 0.014 CID_154699900 | CID_154699900 | |
| 0.2 | 0.008 | 0.2 | CYP2A6 inhibitor | |||
| 0.215 | 0.023 | 0.215 | Catenin beta inhibitor | |||
| 0.198 | 0.007 | 0.198 | DOPA decarboxylase inhibitor | |||
| 0.205 | 0.014 | 0.501 | Mediator release inhibitor | 0.501 0.004 CID_154699900 | CID_154699900 | |
| 0.214 | 0.024 | 0.214 | DNA polymerase I inhibitor | 0.207 0.026 CID_154699900 | ||
| 0.199 | 0.01 | 0.199 | HIV-1 integrase (3'-Processing) inhibitor | 0.101 0.025 CID_154699900 | ||
| 0.225 | 0.036 | 0.225 | Cholinergic | |||
| 0.201 | 0.013 | 0.567 | Beta glucuronidase inhibitor | 0.567 0.003 CID_154699900 | CID_154699900 | |
| 0.198 | 0.009 | 0.198 | HIV-1 integrase (Strand Transfer) inhibitor | 0.097 0.024 CID_154699900 | ||
| 0.217 | 0.03 | 0.355 | Alpha-N-acetylglucosaminidase inhibitor | 0.355 0.011 CID_154699900 | CID_154699900 | |
| 0.228 | 0.042 | 0.228 | Amyloid beta precursor protein antagonist | |||
| 0.204 | 0.021 | 0.204 | Butyrylcholinesterase inhibitor | |||
| 0.209 | 0.027 | 0.209 | Protein-tyrosine phosphatase 1B inhibitor | 0.201 0.029 CID_154699900 | ||
| 0.196 | 0.014 | 0.196 | Telomerase inhibitor | |||
| 0.207 | 0.027 | 0.207 | Arachidonic acid antagonist | 0.133 0.109 CID_154699900 | ||
| 0.189 | 0.013 | 0.189 | TRPA1 agonist | 0.113 0.068 CID_154699900 | ||
| 0.177 | 0.004 | 0.177 | ATPase (Vacuolar H+) inhibitor | 0.174 0.004 CID_154699900 | ||
| 0.184 | 0.013 | 0.184 | Protein kinase C zeta inhibitor | |||
| 0.226 | 0.058 | 0.465 | Platelet adhesion inhibitor | 0.465 0.007 CID_154699900 | CID_154699900 | |
| 0.192 | 0.026 | 0.192 | Chelator | |||
| 0.176 | 0.01 | 0.176 | Aromatase inhibitor | |||
| 0.173 | 0.007 | 0.173 | Carbonic anhydrase VB inhibitor | |||
| 0.186 | 0.022 | 0.186 | MAP3K9 inhibitor | |||
| 0.173 | 0.01 | 0.173 | Carbonic anhydrase V inhibitor | |||
| 0.199 | 0.037 | 0.199 | Tubulin antagonist | |||
| 0.176 | 0.017 | 0.176 | Androgen antagonist | |||
| 0.184 | 0.025 | 0.457 | Cyclooxygenase 3 inhibitor | 0.457 0.004 CID_154699900 | CID_154699900 | |
| 0.217 | 0.058 | 0.217 | Insulin sensitizer | 0.199 0.074 CID_154699900 | ||
| 0.194 | 0.036 | 0.194 | NADPH oxidase inhibitor | 0.135 0.066 CID_154699900 | ||
| 0.177 | 0.019 | 0.177 | GABA C receptor antagonist | |||
| 0.171 | 0.014 | 0.171 | GABA C receptor rho-1 antagonist | |||
| 0.187 | 0.031 | 0.187 | CF transmembrane conductance regulator agonist | 0.138 0.1 CID_154699900 | ||
| 0.161 | 0.01 | 0.161 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.168 | 0.023 | 0.168 | Protein kinase C gamma inhibitor | |||
| 0.197 | 0.051 | 0.197 | Heat shock protein 90 alpha antagonist | |||
| 0.151 | 0.006 | 0.151 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.194 | 0.049 | 0.194 | Protein kinase C nu inhibitor | |||
| 0.194 | 0.048 | 0.194 | Phospholipase C inhibitor | 0.162 0.084 CID_154699900 | ||
| 0.154 | 0.01 | 0.154 | Carbonic anhydrase VA inhibitor | |||
| 0.229 | 0.084 | 0.375 | DNA synthesis inhibitor | 0.375 0.025 CID_154699900 | CID_154699900 | |
| 0.163 | 0.02 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.155 0.032 CID_154699900 | ||
| 0.15 | 0.011 | 0.151 | Aldose reductase inhibitor | 0.151 0.011 CID_154699900 | CID_154699900 | |
| 0.257 | 0.12 | 0.481 | Cholesterol antagonist | 0.481 0.036 CID_154699900 | CID_154699900 | |
| 0.219 | 0.082 | 0.219 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.142 | 0.007 | 0.142 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.139 | 0.005 | 0.252 | Carbonic anhydrase XIV inhibitor | 0.252 0.004 CID_154699900 | CID_154699900 | |
| 0.151 | 0.017 | 0.151 | Interleukin 1 beta converting enzyme inhibitor | 0.084 0.083 CID_154699900 | ||
| 0.141 | 0.008 | 0.141 | Protein kinase C eta inhibitor | 0.08 0.024 CID_154699900 | ||
| 0.146 | 0.013 | 0.231 | Carbonic anhydrase XII inhibitor | 0.231 0.007 CID_154699900 | CID_154699900 | |
| 0.143 | 0.011 | 0.143 | Alcohol oxidase inhibitor | |||
| 0.161 | 0.03 | 0.161 | GABA C receptor agonist | |||
| 0.167 | 0.037 | 0.167 | Cholesterol synthesis inhibitor | 0.115 0.069 CID_154699900 | ||
| 0.209 | 0.079 | 0.209 | Interleukin antagonist | |||
| 0.182 | 0.053 | 0.376 | Diuretic | 0.376 0.014 CID_154699900 | CID_154699900 | |
| 0.155 | 0.027 | 0.321 | DNA repair enzyme inhibitor | 0.321 0.004 CID_154699900 | CID_154699900 | |
| 0.131 | 0.006 | 0.131 | Estrogen receptor alpha agonist | |||
| 0.144 | 0.021 | 0.144 | Anabolic | |||
| 0.315 | 0.193 | 0.315 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.249 | 0.127 | 0.653 | Antithrombotic | 0.653 0.011 CID_154699900 | CID_154699900 | |
| 0.127 | 0.011 | 0.127 | D-Ala-D-Ala ligase inhibitor | |||
| 0.124 | 0.009 | 0.124 | Androgen agonist | |||
| 0.127 | 0.013 | 0.127 | HIV-1 integrase inhibitor | |||
| 0.173 | 0.059 | 0.173 | Neurotensin receptor agonist | |||
| 0.14 | 0.026 | 0.14 | Prolactin inhibitor | |||
| 0.132 | 0.018 | 0.132 | Keratolytic | |||
| 0.141 | 0.032 | 0.317 | UDP-glucose 4-epimerase inhibitor | 0.317 0.009 CID_154699900 | CID_154699900 | |
| 0.154 | 0.045 | 0.289 | Alkylator | 0.289 0.013 CID_154699900 | CID_154699900 | |
| 0.157 | 0.05 | 0.157 | MAP kinase kinase 4 inhibitor | |||
| 0.12 | 0.016 | 0.159 | Carbonic anhydrase IX inhibitor | 0.159 0.011 CID_154699900 | CID_154699900 | |
| 0.141 | 0.038 | 0.141 | Mucolytic | 0.138 0.04 CID_154699900 | ||
| 0.153 | 0.05 | 0.153 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.156 | 0.053 | 0.156 | Adenylate cyclase stimulant | |||
| 0.165 | 0.062 | 0.312 | Hexokinase inhibitor | 0.312 0.01 CID_154699900 | CID_154699900 | |
| 0.137 | 0.035 | 0.137 | Transcription factor STAT6 inhibitor | |||
| 0.164 | 0.063 | 0.164 | Phospholipase A2 inhibitor | 0.129 0.102 CID_154699900 | ||
| 0.134 | 0.033 | 0.134 | Urease inhibitor | |||
| 0.112 | 0.013 | 0.112 | Xanthine dehydrogenase inhibitor | |||
| 0.126 | 0.027 | 0.126 | Porphobilinogen synthase inhibitor | |||
| 0.198 | 0.099 | 0.198 | Dyrk kinase inhibitor | |||
| 0.131 | 0.033 | 0.131 | Breast cancer-resistant protein inhibitor | |||
| 0.102 | 0.004 | 0.102 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.129 | 0.035 | 0.129 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.135 | 0.042 | 0.36 | Expectorant | 0.36 0.005 CID_154699900 | CID_154699900 | |
| 0.11 | 0.02 | 0.11 | Caspase 7 inhibitor | |||
| 0.093 | 0.003 | 0.093 | Estrogen-related receptor beta antagonist | |||
| 0.108 | 0.017 | 0.108 | Estrogen-related receptor beta agonist | |||
| 0.103 | 0.012 | 0.103 | Protein kinase C beta inhibitor | |||
| 0.199 | 0.11 | 0.477 | Tumour necrosis factor alpha release inhibitor | 0.477 0.016 CID_154699900 | CID_154699900 | |
| 0.111 | 0.023 | 0.111 | mTOR complex 2 inhibitor | |||
| 0.092 | 0.004 | 0.092 | ATP citrate lysase inhibitor | |||
| 0.111 | 0.024 | 0.111 | Glutamate decarboxylase inhibitor | |||
| 0.094 | 0.01 | 0.094 | Carbonic anhydrase VII inhibitor | 0.046 0.033 CID_154699900 | ||
| 0.111 | 0.028 | 0.193 | Phosphofructokinase-1 inhibitor | 0.193 0.012 CID_154699900 | CID_154699900 | |
| 0.121 | 0.038 | 0.165 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.165 0.022 CID_154699900 | CID_154699900 | |
| 0.123 | 0.041 | 0.179 | Toll-Like receptor 4 antagonist | 0.179 0.01 CID_154699900 | CID_154699900 | |
| 0.107 | 0.025 | 0.107 | Carbonic anhydrase inhibitor | 0.104 0.026 CID_154699900 | ||
| 0.086 | 0.005 | 0.086 | Dopamine D5 agonist | |||
| 0.181 | 0.102 | 0.181 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.118 | 0.039 | 0.28 | Antineoplastic antibiotic | 0.28 0.011 CID_154699900 | CID_154699900 | |
| 0.138 | 0.058 | 0.138 | Antibacterial (Helicobacter pylori) | |||
| 0.089 | 0.01 | 0.089 | Progesterone antagonist | |||
| 0.083 | 0.005 | 0.083 | DNA gyrase subunit A inhibitor | 0.052 0.015 CID_154699900 | ||
| 0.127 | 0.049 | 0.127 | Aminopeptidase B inhibitor | |||
| 0.113 | 0.037 | 0.216 | Triose-phosphate isomerase inhibitor | 0.216 0.009 CID_154699900 | CID_154699900 | |
| 0.101 | 0.025 | 0.101 | Leukotriene synthesis inhibitor | |||
| 0.11 | 0.036 | 0.163 | Phosphodiesterase 6D inhibitor | 0.163 0.007 CID_154699900 | CID_154699900 | |
| 0.091 | 0.017 | 0.091 | Glutamate (mGluR7) antagonist | |||
| 0.083 | 0.009 | 0.083 | Acetyl-CoA transferase 2 inhibitor | 0.057 0.038 CID_154699900 | ||
| 0.091 | 0.018 | 0.091 | Aryl hydrocarbon receptor antagonist | |||
| 0.108 | 0.036 | 0.187 | NADH dehydrogenase inhibitor | 0.187 0.012 CID_154699900 | CID_154699900 | |
| 0.144 | 0.072 | 0.144 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.099 | 0.028 | 0.099 | GABA aminotransferase inhibitor | 0.083 0.043 CID_154699900 | ||
| 0.168 | 0.096 | 0.168 | Anesthetic general | 0.146 0.119 CID_154699900 | ||
| 0.107 | 0.037 | 0.107 | Ornithine decarboxylase inhibitor | |||
| 0.127 | 0.057 | 0.127 | Protein kinase (CK2) alpha inhibitor | |||
| 0.101 | 0.031 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.123 0.015 CID_154699900 | CID_154699900 | |
| 0.128 | 0.059 | 0.128 | Proteasome inhibitor | |||
| 0.118 | 0.05 | 0.118 | Protein kinase (CK2) inhibitor | |||
| 0.083 | 0.015 | 0.083 | Transcription factor RelA inhibitor | |||
| 0.102 | 0.035 | 0.102 | Glutathione S-transferase inhibitor | |||
| 0.16 | 0.094 | 0.263 | DNA methyltransferase I inhibitor | 0.263 0.042 CID_154699900 | CID_154699900 | |
| 0.104 | 0.037 | 0.109 | Glutamate release inhibitor | 0.109 0.031 CID_154699900 | CID_154699900 | |
| 0.072 | 0.007 | 0.072 | Sirtuin 2 inhibitor | |||
| 0.193 | 0.128 | 0.32 | Interleukin agonist | 0.32 0.039 CID_154699900 | CID_154699900 | |
| 0.116 | 0.052 | 0.344 | AMP-activated protein kinase stimulant | 0.344 0.004 CID_154699900 | CID_154699900 | |
| 0.096 | 0.032 | 0.096 | Thioredoxin reductase inhibitor | |||
| 0.09 | 0.026 | 0.09 | GABA B receptor agonist | |||
| 0.156 | 0.093 | 0.156 | Tumour necrosis factor antagonist | |||
| 0.085 | 0.022 | 0.085 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.073 0.029 CID_154699900 | ||
| 0.088 | 0.028 | 0.088 | Elastase 1 inhibitor | |||
| 0.072 | 0.013 | 0.072 | Squalene epoxidase inhibitor | |||
| 0.103 | 0.046 | 0.103 | Antineoplastic alkaloid | |||
| 0.133 | 0.077 | 0.133 | Histone deacetylase SIRT1 inhibitor | |||
| 0.159 | 0.104 | 0.173 | P-glycoprotein inhibitor | 0.173 0.086 CID_154699900 | CID_154699900 | |
| 0.162 | 0.107 | 0.271 | DNA methylase inhibitor | 0.271 0.038 CID_154699900 | CID_154699900 | |
| 0.071 | 0.016 | 0.071 | Topoisomerase II beta inhibitor | 0.052 0.03 CID_154699900 | ||
| 0.073 | 0.019 | 0.073 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.103 | 0.05 | 0.103 | Protein kinase C delta inhibitor | |||
| 0.086 | 0.033 | 0.086 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.101 | 0.048 | 0.101 | Bile acid receptor antagonist | |||
| 0.1 | 0.048 | 0.137 | Thioredoxin inhibitor | 0.137 0.021 CID_154699900 | CID_154699900 | |
| 0.116 | 0.065 | 0.151 | Microtubule formation inhibitor | 0.151 0.037 CID_154699900 | CID_154699900 | |
| 0.064 | 0.013 | 0.064 | DNA-dependent protein kinase inhibitor | |||
| 0.085 | 0.034 | 0.085 | MAP kinase kinase 7 inhibitor | |||
| 0.107 | 0.057 | 0.107 | Adenylate kinase inhibitor | |||
| 0.128 | 0.079 | 0.128 | Toll-Like receptor 9 antagonist | |||
| 0.072 | 0.023 | 0.072 | Fatty acid synthase inhibitor | |||
| 0.064 | 0.015 | 0.09 | Glucose-6-phosphate isomerase inhibitor | 0.09 0.006 CID_154699900 | CID_154699900 | |
| 0.093 | 0.044 | 0.093 | Myeloperoxidase inhibitor | |||
| 0.199 | 0.151 | 0.199 | Gastrin inhibitor | |||
| 0.063 | 0.015 | 0.063 | Thymidylate synthase inhibitor | |||
| 0.085 | 0.038 | 0.085 | Lipase inhibitor | |||
| 0.062 | 0.015 | 0.062 | Cholesterol esterase inhibitor | |||
| 0.076 | 0.03 | 0.076 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.109 | 0.064 | 0.109 | Electron transport complex I inhibitor | |||
| 0.051 | 0.007 | 0.051 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.074 | 0.032 | 0.074 | Glutamate (mGluR6) antagonist | |||
| 0.099 | 0.057 | 0.099 | MAP kinase kinase 1 inhibitor | |||
| 0.081 | 0.039 | 0.081 | MAP3K7 inhibitor | |||
| 0.1 | 0.059 | 0.1 | Sphingomyelinase inhibitor | 0.096 0.064 CID_154699900 | ||
| 0.117 | 0.077 | 0.117 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.207 | 0.168 | 0.207 | Vasodilator, peripheral | |||
| 0.078 | 0.041 | 0.078 | Glycine receptor agonist | |||
| 0.095 | 0.058 | 0.142 | Uric acid excretion stimulant | 0.142 0.026 CID_154699900 | CID_154699900 | |
| 0.061 | 0.025 | 0.061 | Aconitate hydratase inhibitor | |||
| 0.051 | 0.015 | 0.051 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.126 | 0.091 | 0.126 | Farnesoid X receptor antagonist | |||
| 0.038 | 0.005 | 0.038 | Complement factor 1r inhibitor | |||
| 0.041 | 0.009 | 0.041 | Dopamine autoreceptor agonist | |||
| 0.065 | 0.033 | 0.065 | Heat shock protein 90 beta antagonist | |||
| 0.043 | 0.012 | 0.043 | Catechol O-methyltransferase inhibitor | |||
| 0.049 | 0.02 | 0.049 | GABA B receptor antagonist | |||
| 0.076 | 0.047 | 0.076 | Cathepsin G inhibitor | |||
| 0.037 | 0.009 | 0.037 | Estrone sulfatase inhibitor | |||
| 0.177 | 0.149 | 0.177 | Streptokinase A inhibitor | |||
| 0.043 | 0.016 | 0.043 | Estrogen-related receptor alpha antagonist | |||
| 0.07 | 0.045 | 0.07 | Sirtuin 1 inhibitor | |||
| 0.122 | 0.097 | 0.275 | Cell wall synthesis inhibitor | 0.275 0.012 CID_154699900 | CID_154699900 | |
| 0.045 | 0.021 | 0.045 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.063 | 0.04 | 0.063 | Purinergic P2X1 antagonist | |||
| 0.042 | 0.019 | 0.042 | Nicotinic acid receptor agonist | |||
| 0.046 | 0.024 | 0.046 | Nerve growth factor antagonist | |||
| 0.146 | 0.125 | 0.146 | Antimitotic | |||
| 0.055 | 0.034 | 0.072 | Leukotriene B4 antagonist | 0.072 0.019 CID_154699900 | CID_154699900 | |
| 0.055 | 0.035 | 0.055 | Acetyl-CoA transferase inhibitor | |||
| 0.062 | 0.041 | 0.062 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.059 | 0.04 | 0.059 | Ryanodine receptor antagonist | |||
| 0.099 | 0.08 | 0.127 | Multidrug resistance-associated protein 1 inhibitor | 0.127 0.041 CID_154699900 | CID_154699900 | |
| 0.072 | 0.053 | 0.072 | Catalase inhibitor | |||
| 0.077 | 0.059 | 0.077 | Chymotrypsin inhibitor | |||
| 0.091 | 0.074 | 0.091 | Bronchodilator | |||
| 0.105 | 0.089 | 0.105 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.115 | 0.099 | 0.115 | Vanilloid 1 agonist | |||
| 0.103 | 0.087 | 0.103 | Histone deacetylase class III inhibitor | |||
| 0.124 | 0.109 | 0.124 | Sigma receptor agonist | |||
| 0.018 | 0.004 | 0.018 | Progesterone receptor A antagonist | |||
| 0.07 | 0.056 | 0.07 | Glutamate dehydrogenase inhibitor | |||
| 0.054 | 0.041 | 0.065 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.065 0.03 CID_154699900 | CID_154699900 | |
| 0.088 | 0.076 | 0.088 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.035 | 0.024 | 0.035 | Opioid delta receptor agonist | |||
| 0.049 | 0.038 | 0.049 | Potassium channel (Inward rectifier) activator | |||
| 0.067 | 0.058 | 0.067 | Aminopeptidase I inhibitor | |||
| 0.067 | 0.058 | 0.116 | Histone deacetylase SIRT1 stimulant | 0.116 0.019 CID_154699900 | CID_154699900 | |
| 0.067 | 0.058 | 0.116 | Histone deacetylase stimulant | 0.116 0.019 CID_154699900 | CID_154699900 | |
| 0.034 | 0.025 | 0.034 | Retinoid X alpha receptor agonist | |||
| 0.059 | 0.051 | 0.059 | CDC25B inhibitor | |||
| 0.061 | 0.053 | 0.061 | Beta 3 adrenoreceptor antagonist | |||
| 0.093 | 0.085 | 0.093 | 5 Hydroxytryptamine 3A agonist | |||
| 0.138 | 0.132 | 0.138 | MAP kinase kinase 2 inhibitor | |||
| 0.051 | 0.046 | 0.051 | DNA helicase inhibitor | |||
| 0.048 | 0.043 | 0.104 | Glucose-6-phosphate translocase inhibitor | 0.104 0.005 CID_154699900 | CID_154699900 | |
| 0.022 | 0.018 | 0.022 | ICAM 1 antagonist | |||
| 0.053 | 0.049 | 0.053 | Leukotriene C antagonist | |||
| 0.036 | 0.032 | 0.036 | Vanilloid 3 antagonist | |||
| 0.031 | 0.028 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.048 | 0.045 | 0.048 | Carbonic anhydrase I inhibitor | |||
| 0.058 | 0.055 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.088 | 0.086 | 0.088 | Ferrochelatase inhibitor | |||
| 0.026 | 0.025 | 0.026 | Estrogen-related receptor gamma antagonist | |||
| 0.035 | 0.034 | 0.035 | Glutamate (mGluR8) agonist | |||
| 0.041 | 0.04 | 0.041 | Potassium channel Kv1.3 blocker | |||
| 0.048 | 0.049 | 0.101 | Alpha-mannosidase inhibitor | 0.101 0.006 CID_154699900 | CID_154699900 | |
| 0.055 | 0.058 | 0.085 | Nitric oxide donor | 0.085 0.018 CID_154699900 | CID_154699900 | |
| 0.07 | 0.074 | 0.115 | Glycine receptor antagonist | 0.115 0.021 CID_154699900 | CID_154699900 | |
| 0.017 | 0.021 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 CID_154699900 | CID_154699900 | |
| 0.056 | 0.064 | 0.104 | Neuraminidase (influenza) inhibitor | 0.104 0.015 CID_154699900 | CID_154699900 | |
| 0.116 | 0.124 | 0.406 | Hemostatic | 0.406 0.007 CID_154699900 | CID_154699900 | |
| 0.021 | 0.033 | 0.103 | Sodium/glucose cotransporter 2 inhibitor | 0.103 0.003 CID_154699900 | CID_154699900 | |
| 0.013 | 0.025 | 0.018 | Telomerase stimulant | 0.018 0.01 CID_154699900 | CID_154699900 | |
| 0.141 | 0.154 | 0.356 | Platelet antagonist | 0.356 0.037 CID_154699900 | CID_154699900 | |
| 0.02 | 0.034 | 0.032 | Vanilloid 2 agonist | 0.032 0.007 CID_154699900 | CID_154699900 | |
| 0.036 | 0.049 | 0.102 | Mannosidase inhibitor | 0.102 0.005 CID_154699900 | CID_154699900 | |
| 0.023 | 0.039 | 0.054 | Arginase inhibitor | 0.054 0.013 CID_154699900 | CID_154699900 | |
| 0.006 | 0.027 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 CID_154699900 | CID_154699900 | |
| 0.02 | 0.043 | 0.085 | Sodium/glucose cotransporter inhibitor | 0.085 0.003 CID_154699900 | CID_154699900 | |
| 0.118 | 0.144 | 0.741 | Angiogenesis stimulant | 0.741 0.004 CID_154699900 | CID_154699900 | |
| 0.062 | 0.089 | 0.087 | Interferon agonist | 0.087 0.042 CID_154699900 | CID_154699900 | |
| 0.046 | 0.075 | 0.065 | Adenine nucleotide translocase inhibitor | 0.065 0.02 CID_154699900 | CID_154699900 | |
| 0.04 | 0.078 | 0.118 | Heparanase inhibitor | 0.118 0.003 CID_154699900 | CID_154699900 | |
| 0.125 | 0.167 | 0.316 | Hypolipemic | 0.316 0.044 CID_154699900 | CID_154699900 | |
| 0.03 | 0.073 | 0.058 | Neuraminidase (Influenza A) inhibitor | 0.058 0.014 CID_154699900 | CID_154699900 | |
| 0.035 | 0.084 | 0.088 | Neuraminidase inhibitor | 0.088 0.021 CID_154699900 | CID_154699900 | |
| 0.036 | 0.088 | 0.052 | Cytokine production stimulant | 0.052 0.025 CID_154699900 | CID_154699900 | |
| 0.072 | 0.13 | 0.107 | Interleukin 12 antagonist | 0.107 0.043 CID_154699900 | CID_154699900 | |
| 0.144 | 0.211 | 0.392 | Peptidyltransferase inhibitor | 0.392 0.007 CID_154699900 | CID_154699900 | |
| 0.002 | 0.074 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_154699900 | CID_154699900 | |
| 0.036 | 0.112 | 0.05 | Factor III inhibitor | 0.05 0.034 CID_154699900 | CID_154699900 | |
| 0.067 | 0.146 | 0.098 | T cell inhibitor | 0.098 0.026 CID_154699900 | CID_154699900 | |
| 0.094 | 0.175 | 0.281 | Insulin secretagoues | 0.281 0.015 CID_154699900 | CID_154699900 | |
| 0.025 | 0.108 | 0.115 | Protein 50S ribosomal subunit inhibitor | 0.115 0.01 CID_154699900 | CID_154699900 | |
| 0.01 | 0.095 | 0.022 | Dopamine D1 agonist | 0.022 0.018 CID_154699900 | CID_154699900 | |
| 0.037 | 0.128 | 0.072 | DNA gyrase inhibitor | 0.072 0.034 CID_154699900 | CID_154699900 | |
| 0.025 | 0.117 | 0.049 | Microtubule stabilization | 0.049 0.03 CID_154699900 | CID_154699900 | |
| 0.16 | 0.272 | 0.411 | Interleukin 2 agonist | 0.411 0.024 CID_154699900 | CID_154699900 | |
| 0.012 | 0.124 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.022 CID_154699900 | CID_154699900 | |
| 0.067 | 0.182 | 0.324 | Thrombolytic | 0.324 0.02 CID_154699900 | CID_154699900 | |
| 0.04 | 0.168 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 CID_154699900 | CID_154699900 | |
| 0.01 | 0.142 | 0.058 | Protein 30S ribosomal subunit inhibitor | 0.058 0.006 CID_154699900 | CID_154699900 | |
| 0.103 | 0.245 | 0.145 | CC chemokine 6 receptor antagonist | 0.145 0.03 CID_154699900 | CID_154699900 | |
| 0.123 | 0.282 | 0.299 | Angiogenesis inhibitor | 0.299 0.093 CID_154699900 | CID_154699900 | |
| 0.005 | 0.209 | 0.029 | Squalene synthetase inhibitor | 0.029 0.024 CID_154699900 | CID_154699900 | |
| 0.017 | 0.225 | 0.079 | Antibiotic Aminoglycoside-like | 0.079 0.005 CID_154699900 | CID_154699900 | |
| 0.016 | 0.238 | 0.367 | Selectin antagonist | 0.367 0.004 CID_154699900 | CID_154699900 | |
| 0.139 | 0.382 | 0.766 | Cyclophilin D inhibitor | 0.766 0.009 CID_154699900 | CID_154699900 | |
| 0.035 | 0.33 | 0.076 | Falcipain 2 inhibitor | 0.076 0.074 CID_154699900 | CID_154699900 | |
| 0.035 | 0.338 | 0.078 | Falcipain inhibitor | 0.078 0.076 CID_154699900 | CID_154699900 | |
| 0.037 | 0.37 | 0.245 | Anticoagulant | 0.245 0.04 CID_154699900 | CID_154699900 | |
| 0.039 | 0.384 | 0.128 | Transcription factor NF kappa B stimulant | 0.128 0.022 CID_154699900 | CID_154699900 | |
| 0.011 | 0.497 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.011 CID_154699900 | CID_154699900 | |
| 0.026 | 0.52 | 0.22 | Cell adhesion inhibitor | 0.22 0.02 CID_154699900 | CID_154699900 | |
| 0.015 | 0.511 | 0.11 | Cell adhesion molecule inhibitor | 0.11 0.028 CID_154699900 | CID_154699900 | |
| 0.016 | 0.513 | 0.079 | Factor IXa inhibitor | 0.079 0.016 CID_154699900 | CID_154699900 | |
| 0.017 | 0.823 | 0.32 | Immunomodulator | 0.32 0.072 CID_154699900 | CID_154699900 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |